摘要
目的探究沙美特罗替卡松粉吸入剂(舒利迭)联合噻托溴铵治疗老年支气管哮喘的疗效。方法选取120例老年支气管哮喘患者随机分为试验组(60例)和对照组(60例),在一般治疗基础上,对照组给予舒利迭吸入;实验组给予舒利迭联合噻托溴铵吸入,疗程均为4周,观察两组治疗效果。结果治疗4周后,实验组控制率及临床症状评分均高于对照组,实验组治疗2周和4周的FEVI占预计值百分比和△PEF改善好于对照组,两组治疗均未出现严重不良反应。患者平均治疗费用实验组同对照组比较差异无统计学意义(P>0.05)。结论老年支气管哮喘患者选择舒利迭联合噻托溴铵吸入可提高疗效,且治疗费用增加不明显。
Objective To explore the effect of tiotropium combined Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation（Shu Lidie）the curative effect in treatment of senile bronchial asthma.Methods 120 cases of elderly patients with bronchial asthma were randomly divided into experimental group（60 cases）and control group（60 cases）,on the basis of the general treatment,the control group was given Seretide;the experimental group was given tiotropium combined with Seretide inhalation for 4 weeks,to observe the therapeutic effect of two groups.Results After 4 weeks of treatment,the control rate and clinical symptorn scores of the experimental group were higher than those of the control group.The percentage of FEVI in the experimental group at 2 and 4 weeks of treatment accounted for the predicted value and the improvemnet of △PEP was better than that of the control group.Conclusion Patients with bronchial asthma were selected tiotropium combined with Seretide inhalation can improve the efficacy,and the treatment cost increase is not obvious.
作者
廖振辉
杨龙峰
刘国栋
谭经福
陈勇
Liao Zhenhui;Yang Longfeng;Liu Guodong;Tan Jingfu;Chen Yong(Respiratory Medicine,Heyuan People＇s Hospital,Heyuan 517400,China)
出处
《哈尔滨医药》
2018年第4期310-311,共2页
Harbin Medical Journal
关键词
噻托溴铵
沙美特罗替卡松粉吸入剂
老年支气管哮喘
Tiotropium bromide
Salmeterol xinafoate and fluticasone propionate powder for inhalation
Bronchial asthma in the elderly
